Type of supplemented simple sugar, not merely calorie intake, determines adverse effects on metabolism and aortic function in female rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 312, Issue 2, 2017, Pages H289-H304

  Sangüesa, Gemma ^a   Shaligram, Sonali ^b   Akther, Farjana ^b   Roglans, Núria ^a,c   Laguna, Juan C ^a,c   Rahimian, Roshanak ^b   Alegret, Marta ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF THE PACIFIC   (United States)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

Adiponectin; Fructose; Glucose; Insulin resistance; Liver

Indexed keywords

ADIPONECTIN; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRUCTOSE; GLUCOSE; INSULIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHENYLEPHRINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; ACETYLCHOLINE; ADIPOQ PROTEIN, RAT; BRADYKININ; CARRIER PROTEIN; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; NOS3 PROTEIN, RAT; SUGAR INTAKE;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; AORTIC TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CALORIC INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOGENESIS; LIVER TISSUE; LIVER WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; DRUG EFFECTS; LIVER; METABOLISM; PATHOPHYSIOLOGY; PHARMACOLOGY; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ACETYLCHOLINE; ADIPONECTIN; ANIMALS; AORTA; BLOTTING, WESTERN; BRADYKININ; CARNITINE O-PALMITOYLTRANSFERASE; CARRIER PROTEINS; DIETARY SUCROSE; ENERGY INTAKE; FEMALE; FRUCTOSE; GLUCOSE; INSULIN; LIPID METABOLISM; LIPOGENESIS; LIVER; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; PHENYLEPHRINE; PHOSPHORYLATION; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRIGLYCERIDES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 85011343031     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00339.2016     Document Type: Article

References (60)

1. Agius L. High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload. Biochem Pharmacol 85: 306-312, 2013. doi:10.1016/j.bcp.2012.09.019.
2. Akar F, Uludag˘ O, Aydın A, Aytekin YA, Elbeg S, Tuzcu M, Sahin K. High-fructose corn syrup causes vascular dysfunction associated with metabolic disturbance in rats: protective effect of resveratrol. Food Chem Toxicol 50: 2135-2141, 2012. doi:10.1016/j.fct.2012.03.061.
3. Alegret M, Roglans N, Laguna JC. Fructose consumption and leptin resistance: what have we learnt from animal studies? In: Leptin: Hormonal Fuctions, Dysfunctions and Clinical Uses, edited by Hemling RM, Belkin AT. Hauppauge, NY: Nova Science, 2011.
4. Aszódi A, Pfeifer A, Ahmad M, Glauner M, Zhou XH, Ny L, Andersson KE, Kehrel B, Offermanns S, Fässler R. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP-and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 18: 37-48, 1999. doi:10.1093/emboj/18.1.37.
5. Babacanoglu C, Yildirim N, Sadi G, Pektas MB, Akar F. Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats. Food Chem Toxicol 60: 160-167, 2013. doi:10.1016/j.fct.2013.07.026.
6. Baena M, Sangüesa G, Dávalos A, Latasa M-J, Sala-Vila A, Sánchez RM, Roglans N, Laguna JC, Alegret M. Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues. Sci Rep 6: 26149, 2016. doi:10.1038/srep26149.
7. Baena M, Sangüesa G, Hutter N, Sánchez RM, Roglans N, Laguna JC, Alegret M. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress. Biochim Biophys Acta 1851: 107-116, 2015. doi:10.1016/j.bbalip.2014.11.003.
8. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94: 3341-3347, 1996. doi:10.1161/01.CIR.94.12.3341.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976. doi:10.1016/0003-2697(76)90527-3.
10. Bray GA, Popkin BM. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar. Diabetes Care 37: 950-956, 2014. doi:10.2337/dc13-2085.
11. Carpentier A, Taghibiglou C, Leung N, Szeto L, Van Iderstine SC, Uffelman KD, Buckingham R, Adeli K, Lewis GF. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277: 28795-28802, 2002. doi:10.1074/jbc.M204568200.
12. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278: 45021-45026, 2003. doi:10.1074/jbc.M307878200.
13. Csanyi G, Lepran I, Flesch T, Telegdy G, Szabo G, Mezei Z. Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats. Pharmacol Rep 59: 447-455, 2007.
14. DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 108, Suppl: 3B-24B, 2011. doi:10.1016/j.amjcard.2011.03.013.
15. Deng G, Long Y, Yu Y-R, Li M-R. Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway. Int J Obes (Lond) 34: 165-171, 2010. doi:10.1038/ijo.2009.205.
16. Develi-Is S, Ozen G, Bekpinar S, Topal G, Unlucerci Y, Dogan BSU, Uysal M. Resveratrol improves high-fructose-induced vascular dysfunc-tion in rats. Can J Physiol Pharmacol 92: 1021-1027, 2014. doi:10.1139/cjpp-2014-0245.
17. Gordon DA, Jamil H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim Biophys Acta 1486: 72-83, 2000. doi:10.1016/S1388-1981(00)00049-4.
18. Han X, Shaligram S, Zhang R, Anderson L, Rahimian R. Sex-specific vascular responses of the rat aorta: effects of moderate term (intermediate stage) streptozotocin-induced diabetes. Can J Physiol Pharmacol 94: 408-415, 2016. doi:10.1139/cjpp-2015-0272.
19. Han X, Zhang R, Anderson L, Rahimian R. Sexual dimorphism in rat aortic endothelial function of streptozotocin-induced diabetes: possible involvement of superoxide and nitric oxide production. Eur J Pharmacol 723: 442-450, 2014. doi:10.1016/j.ejphar.2013.10.052.
20. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A 89: 11259-11263, 1992. doi:10.1073/pnas.89.23.11259.
21. Herrero L, Rubí B, Sebastián D, Serra D, Asins G, Maechler P, Prentki M, Hegardt FG. Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the beta-cell impairs glucose-induced insulin secretion. Diabetes 54: 462-471, 2005. doi:10.2337/diabetes.54.2.462.
22. Imamura F, O’Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, Forouhi NG. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ 351: h3576, 2015. doi:10.1136/bmj.h3576.
23. Iyer SN, Katovich MJ. Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin Exp Hypertens 18: 227-242, 1996. doi:10.3109/10641969609081766.
24. Jeon TI, Osborne TF. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23: 65-72, 2012. doi:10.1016/j.tem.2011.10.004.
25. Jia G, Aroor AR, Whaley-Connell AT, Sowers JR. Fructose and uric acid: is there a role in endothelial function? Curr Hypertens Rep 16: 434, 2014. doi:10.1007/s11906-014-0434-z.
26. Kahn R, Sievenpiper JL. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: we have, but the pox on sugar is overwrought and overworked. Diabetes Care 37: 957-962, 2014. doi:10.2337/dc13-2506.
27. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113: 1888-1904, 2006. doi:10.1161/CIRCULATIONAHA.105.563213.
28. Leary S, Underwood W, Anthony R, Cartner S, Corey D, Grandin T, Greenacre CB, Gwaltney-Bran S, McCrackin MA, Meyer R, Miller D, Shearer J, Yanong R. AVMA Guidelines for the Euthanasia of Animals 2013 Edition. Schaumburg, IL: American Veterinary Medical Association, 2013.
29. Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116: 571-580, 2006. doi:10.1172/JCI27989.
30. Lorber D. Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 7: 169-183, 2014. doi:10.2147/DMSO.S61438.
31. Mahmoud MF, El-Nagar M, El-Bassossy HM. Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats. Arch Pharm Res 35: 155-162, 2012. doi:10.1007/s12272-012-0117-8.
32. Malik VS, Hu FB. Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us. J Am Coll Cardiol 66: 1615-1624, 2015. doi:10.1016/j.jacc.2015.08.025.
33. Mourmoura E, Vial G, Laillet B, Rigaudière J-P, Hininger-Favier I, Dubouchaud H, Morio B, Demaison L. Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo. Cardiovasc Diabetol 12: 49, 2013. doi:10.1186/1475-2840-12-49.
34. Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 14: 5-12, 2013. doi:10.1007/s11154-012-9229-1.
35. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 289: H2144-H2152, 2005. doi:10.1152/ajpheart.00591.2005.
36. Navarro-Cid J, Maeso R, Pérez-Vizcaíno F, Cachofeiro V, Ruilope LM, Tamargo J, Lahera V. Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat. Hypertension 26: 1074-1078, 1995. doi:10.1161/01. HYP.26.6.1074.
37. Orellana-GavaldáJM, Herrero L, Malandrino MI, Pañeda A, Sol Rodríguez-Peña M, Petry H, Asins G, Van Deventer S, Hegardt FG, Serra D. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology 53: 821-832, 2011. doi:10.1002/hep.24140.
38. Pektas_ MB, Sadi G, Akar F. Long-term dietary fructose causes genderdifferent metabolic and vascular dysfunction in rats: modulatory effects of resveratrol. Cell Physiol Biochem 37: 1407-1420, 2015. doi:10.1159/000430405.
39. Pereira MA. Sugar-sweetened and artificially-sweetened beverages in relation to obesity risk. Adv Nutr 5: 797-808, 2014. doi:10.3945/an.114.007062.
40. Rahimian R, Laher I, Dube G, van Breemen C. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J Pharmacol Exp Ther 283: 116-122, 1997.
41. Rebollo A, Roglans N, Baena M, Padrosa A, Sánchez RM, Merlos M, Alegret M, Laguna JC. Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats. J Nutr Biochem 25: 250-258, 2014. doi:10.1016/j.jnutbio.2013.10.014.
42. Rebollo A, Roglans N, Baena M, Sánchez RM, Merlos M, Alegret M, Laguna JC. Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells. Biochim Biophys Acta 1841: 514-524, 2014. doi:10.1016/j.bbalip.2014.01.002.
43. Roglans N, Vilá L, Farré M, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 45: 778-788, 2007. doi:10.1002/hep.21499.
44. Schäfer A, Burkhardt M, Vollkommer T, Bauersachs J, Münzel T, Walter U, Smolenski A. Endothelium-dependent and-independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotideelevating vasodilators in rat aorta. Biochem Pharmacol 65: 397-405, 2003. doi:10.1016/S0006-2952(02)01523-X.
45. Sengupta P. The laboratory rat: relating age with human’s. Int J Prev Med 4: 624-630, 2013.
46. Shi Y, Ku DD, Man RYK, Vanhoutte PM. Augmented endotheliumderived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. J Pharmacol Exp Ther 318: 276-281, 2006. doi:10.1124/jpet.105.099739.
47. Shinozaki K, Ayajiki K, Nishio Y, Sugaya T, Kashiwagi A, Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 43: 255-262, 2004. doi:10.1161/01.HYP.0000111136.86976.26.
48. Sluik D, Engelen AI, Feskens EJ. Fructose consumption in the Netherlands: the Dutch National Food Consumption Survey 2007-2010. Eur J Clin Nutr 69: 475-481, 2015. doi:10.1038/ejcn.2014.267.
49. Stanhope KL. Sugar consumption, metabolic disease and obesity: The state of the controversy. Crit Rev Clin Lab Sci 53: 52-67, 2016. doi:10.3109/10408363.2015.1084990.
50. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275: 8416-8425, 2000. doi:10.1074/jbc.275.12.8416.
51. Tappy L, Lê KA, Tran C, Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition 26: 1044-1049, 2010. doi:10.1016/j.nut.2010.02.014.
52. Tappy L, Lê KA. Health effects of fructose and fructose-containing caloric sweeteners: where do we stand 10 years after the initial whistle blowings? Curr Diab Rep 15: 54, 2015. doi:10.1007/s11892-015-0627-0.
53. Vartanian LR, Schwartz MB, Brownell KD. Effects of soft drink consumption on nutrition and health: a systematic review and metaanalysis. Am J Public Health 97: 667-675, 2007. doi:10.2105/AJPH.2005.083782.
54. Vilá L, Rebollo A, Ađalsteisson GS, Alegret M, Merlos M, Roglans N, Laguna JC. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicol Appl Pharmacol 251: 32-40, 2011. doi:10.1016/j.taap.2010.11.011.
55. Vilá L, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC. Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 48: 1506-1516, 2008. doi:10.1002/hep.22523.
56. Vilá L, Roglans N, Perna V, Sánchez RM, Vázquez-Carrera M, Alegret M, Laguna JC. Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. J Nutr Biochem 22: 741-751, 2011. doi:10.1016/j.jnutbio.2010.06.005.
57. Xu X, So J-S, Park J-G, Lee A-H. Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis 33: 301-311, 2013. doi:10.1055/s-0033-1358523.
58. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T. Globular adiponectin protected ob/ob mice from diabetes and ApoEdeficient mice from atherosclerosis. J Biol Chem 278: 2461-2468, 2003. doi:10.1074/jbc.M209033200.
59. Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med 174: 516-524, 2014. doi:10.1001/jamainternmed.2013.13563.
60. Yousif MH, Oriowo MA, Williams KI. Sodium nitroprusside-induced cGMP-independent vasodilator responses in the perfused rabbit ovarian vascular bed. Pharmacol Res 38: 381-386, 1998. doi:10.1006/phrs.1998.0385.